If you have been following the peptide space in Australia for any length of time, you know the TGA has been talking about cracking down for months. This week it actually did something visible. On 17 August the regulator announced a joint operation with NSW Police that pulled more than $120,000 of unapproved peptide and anabolic steroid products out of two residential properties in New South Wales.
The properties were allegedly linked to a social media influencer who, according to the TGA, imported and relabelled the products before advertising and selling them across social media platforms and a dedicated website.
What Was Seized
The seizure list reads like a catalogue of the compounds that dominate Australian community discussion. The TGA named retatrutide, CJC-1295, and what it called the “Wolverine Stack”, which is a combination of BPC-157 and TB-500. Cannabis was also allegedly located at one of the properties and seized by NSW Police.
Search warrants for the two properties were executed on 4 August 2026. The TGA said the influencer had previously been warned by the regulator.
For context, these are the same compounds that show up constantly in research community conversations. Retatrutide is Eli Lilly’s triple agonist that has generated enormous interest off the back of its Phase 3 data. BPC-157 and TB-500 are the tissue repair peptides that have become staples of the wellness and sports community. CJC-1295 is the growth hormone secretagogue that is usually paired with ipamorelin.
None of this is a comment on the compounds themselves. The issue here is that in Australia, unapproved therapeutic goods sit outside the regulatory framework. Imported, relabelled, and sold through social media, these products had not been assessed by the TGA for safety, quality, or effectiveness.
What the TGA Is Saying
The quote from Professor Anthony Lawler, Deputy Secretary of the Department of Health, Disability and Ageing and head of the TGA, gets to the point:
“This operation sends a clear message to people using social media to promote or supply unapproved peptides. Selling or supplying online does not place you outside the law.”
He went on to say that those who unlawfully import, advertise, manufacture, or supply these products risk having them seized, and may receive substantial infringement notices or face civil or criminal court action.
The TGA has been escalating this messaging for a while. Back on 20 July, the regulator warned suppliers, influencers, and online sellers that enforcement was ramping up, with the full suite of powers available including warning letters, infringement notices, product seizures and forfeiture, civil penalties, and criminal prosecution.
Importantly, the July statement made clear that influencers, affiliates, and content creators promoting unapproved peptide products could be held accountable for unlawful advertising even if they were not directly selling the products. That is a direct answer to the question that has been circulating in Australian peptide communities: “I only post about this stuff, I don’t sell it, am I at risk?”
Under the Therapeutic Goods Act 1989, the answer can be yes.
The Penalty Structure
For anyone operating in the grey zone, the numbers matter. Civil penalties for breaches of the Therapeutic Goods Act can reach $1.82 million per breach for individuals and $18.2 million per breach for corporations. Criminal penalties can reach seven years imprisonment.
The TGA has also said it is working directly with social media and e-commerce platforms to remove unlawful advertising and prevent it from reappearing. That is a different enforcement lever to raiding warehouses, and it targets the discovery layer that has driven much of the market’s growth.
What the Research Says
The enforcement action does not change the underlying research picture. Retatrutide remains one of the most studied compounds in the obesity pipeline, with Phase 3 data showing powerful weight loss outcomes. BPC-157 and TB-500 continue to be investigated for tissue repair applications. The question was never whether the research is interesting. It is whether the products people are buying online are what they claim to be, made under controlled conditions, and correctly labelled.
The TGA’s own messaging leans into this. Unapproved peptides, it says, can cause serious health problems including liver damage, severe allergic reactions, and inflammation. When products are imported, relabelled, and resold by an individual with no manufacturing oversight, nobody can verify what is actually in the vial.
What This Means for the Community
This is the second high-visibility enforcement signal in the Australian space in recent months. In June the ABC ran its investigation into how easy it is to buy unapproved peptides. Now the TGA has moved from warnings to warrants.
For the research community the practical takeaways are straightforward:
- Advertising unapproved therapeutic goods directly to Australian consumers is generally prohibited, including through influencer content and affiliate marketing.
- Promotion alone can attract liability, even without direct selling.
- The TGA is actively working with platforms to remove unlawful advertising.
- Product seizures, civil penalties, and criminal prosecution are all on the table.
None of this is legal advice, and the specifics of any individual situation will depend on the facts. But the direction of travel is clear. The TGA has announced it will crack down, and this operation shows it is prepared to follow through.
The Grey Highway community has been discussing the regulatory landscape as it evolves. If you want to see how people are reading these developments, the Telegram community is the place. Our peptides overview and guide to whether peptides are legal in Australia cover the broader regulatory context.
Sources
- TGA Cracks Down on Illegal Peptides, Steroids - Mirage News
- TGA escalates war on unapproved peptides - Medical Republic
Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, therapeutic recommendations, or endorsements of any compound. Grey Highway is a research-education community. We do not sell, supply, or promote the use of research compounds. Always consult a qualified healthcare professional regarding health decisions. For Australian regulatory information, visit the TGA website.